{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:38:42Z","timestamp":1794641922789,"version":"4.9.1"},"reference-count":98,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Both human immunodeficiency virus (HIV) infection and acute myeloid leukemia (AML) may be considered relatively uncommon disorders in the general population, but the precise incidence of AML in people living with HIV infection (PLWH) is uncertain. However, life expectancy of newly infected HIV-positive patients receiving anti-retroviral therapy (ART) is gradually increasing, rivaling that of age-matched HIV-negative individuals, so that the occurrence of AML is also expected to progressively increase. Even if HIV is not reported to be directly mutagenic, several indirect leukemogenic mechanisms, mainly based on bone marrow microenvironment disruption, have been proposed. Despite a well-controlled HIV infection under ART should no longer be considered per se a contraindication to intensive chemotherapeutic approaches, including allogeneic hematopoietic stem cell transplantation, in selected fit patients with AML, survival outcomes are still generally unsatisfactory. We discussed several controversial issues about pathogenesis and clinical management of AML in PLWH, but few evidence-based answers may currently be provided, due to the limited number of cases reported in the literature, mainly as case reports or small retrospective case series. Prospective multicenter clinical trials are warranted to more precisely investigate epidemiology and cytogenetic\/molecular features of AML in PLWH, but also to standardize and further improve its therapeutic management.<\/jats:p>","DOI":"10.3390\/ijms21031081","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T03:13:27Z","timestamp":1581045207000},"page":"1081","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Acute Myeloid Leukemia in Patients Living with HIV Infection: Several Questions, Fewer Answers"],"prefix":"10.3390","volume":"21","author":[{"given":"Fabio","family":"Forghieri","sequence":"first","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5122-5574","authenticated-orcid":false,"given":"Vincenzo","family":"Nasillo","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bettelli","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pioli","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Giusti","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gilioli","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Surgical, Medical, Dental and Morphological Sciences. University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-2542","authenticated-orcid":false,"given":"Enrico","family":"Tagliafico","sequence":"additional","affiliation":[{"name":"Center for Genome Research, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Trenti","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Unit\u00e0 Sanitaria Locale, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-1558","authenticated-orcid":false,"given":"Andrea","family":"Cossarizza","sequence":"additional","affiliation":[{"name":"Section of Immunology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3518-2006","authenticated-orcid":false,"given":"Rossana","family":"Maffei","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Barozzi","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Potenza","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-6878","authenticated-orcid":false,"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Narni","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Policlinico, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1749-6632.1988.tb21631.x","article-title":"Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections","volume":"546","author":"Rosenberg","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/08830185.2014.893301","article-title":"Neutropenia during HIV infection: Adverse consequences and remedies","volume":"33","author":"Shi","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/S2352-3018(18)30179-6","article-title":"Incidence of first and second primary cancers diagnosed among people with HIV, 1985\u20132013: A population-based registry linkage study","volume":"5","author":"Hessol","year":"2018","journal-title":"Lancet HIV"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3389\/fimmu.2019.02267","article-title":"Crossroads of cancer and HIV-1: Pathways to a cure for HIV","volume":"10","author":"Gavegnano","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"ref_6","first-page":"e495","article-title":"Spectrum of cancer risk among HIV-infected people in the United States during the modern antiretroviral therapy era: A population-based registry linkage study","volume":"4","author":"Shields","year":"2017","journal-title":"Lancet HIV"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.6004\/jnccn.2018.0066","article-title":"R.; Barta, S.K.; Carchman, E.; Cohen, A.; Gupta, N.; Johung, K.L.; et al. Cancer in people living with HIV. NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Reid","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignancies in HIV\/AIDS: From epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein","year":"2014","journal-title":"AIDS"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic Disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/ciu174","article-title":"Management of HIV infection in patients with cancer receiving chemotherapy","volume":"59","author":"Torres","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/COH.0000000000000327","article-title":"Evolving epidemiology of HIV-associated malignancies","volume":"12","author":"Shiels","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: A meta-analysis","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1182\/blood-2018-01-791400","article-title":"Optimizing treatment of HIV-associated lymphoma","volume":"134","author":"Noy","year":"2019","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: A population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/596766","article-title":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales EN19 Mortalit\u00e9 Study Group; Mortavic Study Group. Changes in cancer mortality among HIV-infected patients: The Mortalite 2005 survey","volume":"48","author":"Bonnet","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/QAD.0b013e3283112b77","article-title":"Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies","volume":"22","author":"Monforte","year":"2008","journal-title":"AIDS"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_19","unstructured":"(2020, February 05). Available online: https:\/\/www.avert.org\/global-hiv-and-aids-statistics."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","article-title":"Acute myeloid leukaemia","volume":"392","author":"Short","year":"2018","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"vi138","DOI":"10.1093\/annonc\/mdt320","article-title":"Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Fey","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hentrich, M., and Barta, S.K. (2016). HIV Infection and Myelodysplastic Syndrome\/Acute Myeloid Leukemia. HIV-Associated Haematol.ogical Malignancies, Springer International Publishing.","DOI":"10.1007\/978-3-319-26857-6"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1080\/10428194.2019.1633631","article-title":"HIV portends a poor prognosis in myelodysplastic syndromes","volume":"60","author":"Kaner","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Samji, H., Cescon, A., Hogg, R.S., Modur, S.P., Althoff, K.N., Buchacz, K., Burchell, A.N., Cohen, M., Gebo, K.A., and Gill, M.J. (2013). North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081355"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/cid\/ciy012","article-title":"Cancer risk in older people living with human immunodeficiency virus infection in the United States","volume":"67","author":"Mahale","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/cid\/cit369","article-title":"Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy","volume":"57","author":"Yanik","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/QAD.0000000000001077","article-title":"Cancer risk among HIV-infected elderly in the United States","volume":"30","author":"Yanik","year":"2016","journal-title":"AIDS"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an Int.ernational expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.bjc.6604923","article-title":"For the Cancer and AIDS Registries Linkage (CARL) Study. Pattern of cancer risk in persons with AIDS in Italy in the HAART era","volume":"100","author":"Polesel","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/ijc.25153","article-title":"For the Cancer and AIDS Registries Linkage (CARL) Study. Cancer incidence in people with AIDS in Italy","volume":"127","author":"Polesel","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3109\/10428194.2011.624228","article-title":"Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia","volume":"53","author":"Evans","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1002\/cncr.27454","article-title":"Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals","volume":"118","author":"Shiels","year":"2012","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Adult and adolescent spectrum of Disease Project and HIV Outpatient Study Investigators incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann. Int. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1046\/j.1365-2141.2001.02661.x","article-title":"for the French Study Group on Acute Myeloid Leukemia in HIV-infected patients. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: Epidemiology, treatment feasibility and outcome","volume":"112","author":"Sutton","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QAD.0b013e32835a5a7a","article-title":"Non-AIDS-defining hematological malignancies in HIV-infected patients: An epidemiological study in Japan","volume":"27","author":"Hagiwara","year":"2013","journal-title":"AIDS"},{"key":"ref_37","first-page":"374","article-title":"Acute leukemia in HIV patients: Epidemiology, therapeutic strategy and prognosis","volume":"102","author":"Rabian","year":"2017","journal-title":"Haematologica"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1182\/blood.V128.22.4345.4345","article-title":"HIV is associated with a high rate of unexplained multilineage cytopenias and portends a poor prognosis in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)","volume":"128","author":"Kaner","year":"2016","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00002030-200204120-00006","article-title":"Acute myeloid leukemia in patients infected with HIV-1","volume":"16","author":"Aboulafia","year":"2002","journal-title":"AIDS"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/leu.2011.224","article-title":"Commentary: Does immune suppression increase risk of developing acute myeloid leukemia?","volume":"26","author":"Gale","year":"2012","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/bjh.13783","article-title":"Haematological manifestations of human immune deficiency virus infection","volume":"171","author":"Vishnu","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2013033","DOI":"10.4084\/mjhid.2013.033","article-title":"Bone marrow abnormalities in HIV Disease","volume":"3","author":"Dhurve","year":"2013","journal-title":"Mediterr. J. Haematol. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/clinids\/13.2.254","article-title":"Relationship between acute myelomonoblastic leukemia and infection due to human immunodeficiency virus","volume":"13","author":"Murthy","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"ref_44","first-page":"180","article-title":"Chemotherapy of acute myeloblastic leukemia in an HIV carrier","volume":"51","author":"Farber","year":"1993","journal-title":"Clin. J. Haematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ajh.2830490419","article-title":"Third case of acute monocytic leukemia (M5) occuring in an HIV-seropositive man: A case report","volume":"49","author":"Costello","year":"1995","journal-title":"Am. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/infdis\/jit120","article-title":"Hematopoietic stem cells and HIV infection","volume":"2017","author":"Pace","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2109","article-title":"HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs","volume":"16","author":"Carter","year":"2010","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3816\/CLM.2009.n.062","article-title":"Therapy-related acute myeloid leukemia following HIV-associated lymphoma","volume":"9","author":"Mani","year":"2009","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QAD.0000000000002063","article-title":"The Co-morBidity in Relation to AIDS (COBRA) Collaboration. Do people living with HIV experience greater age advancement than their HIV-negative counterparts?","volume":"33","author":"Wit","year":"2019","journal-title":"AIDS"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jaiswal, S., and Ebert, B.L. (2019). Clonal hematopoiesis in human aging and Disease. Science, 366.","DOI":"10.1126\/science.aan4673"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ajcp\/86.6.788","article-title":"Myelodysplasia progressing to acute myeloblastic leukemia in an HTLV-III virus-positive homosexual man with AIDS-related complex","volume":"86","author":"Napoli","year":"1986","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1200\/jco.2012.30.15_suppl.6595","article-title":"Treatment outcome of acute myeloid leukemia (AML) in HIV + patients","volume":"30","author":"Dy","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e18077","DOI":"10.1200\/jco.2015.33.15_suppl.e18077","article-title":"Analysis of a large single center color demonstrates poor prognosis of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in HIV infected patients (pts)","volume":"33","author":"Kaner","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2019-125288","article-title":"Acute leukemia and high-risk myelodysplastic sindrome in HIV-positive patients: 25-years\u2019 experience of the Rete Ematologica Lombarda (REL)","volume":"134","author":"Cattaneo","year":"2019","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.leukres.2012.08.003","article-title":"Clinical and cytogenetic characteristics of myelodysplastic syndrome in patients with HIV infection","volume":"36","author":"Takahashi","year":"2012","journal-title":"Leuk. Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Williamson, B.T., and Leitch, H.A. (2016). Higher risk myelodysplastic syndromes in patients with well-controlled HIV infection: Clinical features, treatment, and outcome. Case Rep. Haematol., 8502641.","DOI":"10.1155\/2016\/8502641"},{"key":"ref_57","first-page":"382","article-title":"Update on the treatment of HIV-associated hematologic malignancies","volume":"2013","author":"Little","year":"2013","journal-title":"Haematol. Am. Soc. Haematol. Educ. Progr. Am."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/hiv.12322","article-title":"EACS Governing Board. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons","volume":"17","author":"Ryom","year":"2016","journal-title":"HIV Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/hiv.12600","article-title":"EACS Governing Board. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0","volume":"19","author":"Ryom","year":"2018","journal-title":"HIV Med."},{"key":"ref_60","first-page":"247","article-title":"Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons","volume":"41","author":"Antinori","year":"2018","journal-title":"New Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41375-018-0139-4","article-title":"Management of patients with acute promyelocytic leukemia","volume":"32","author":"Kayser","year":"2018","journal-title":"Leukemia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"German-Austrian Acute Myeloid Leukemia Study Group; Study Alliance Leukemia. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Avvisati","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","article-title":"Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial","volume":"35","author":"Platzbecker","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European LeukemiaNet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.2169\/internalmedicine.1662-18","article-title":"Two cases of acute promyelocytic leukemia and HIV: Case reports and a Review of the literature","volume":"58","author":"Kunitomi","year":"2019","journal-title":"Int. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.3816\/CLML.2010.n.075","article-title":"Acute promyelocytic leukemia in HIV-infected adults: A case report and Review of therapeutic considerations","volume":"10","author":"Drilon","year":"2010","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/10428199709050899","article-title":"Acute promyelocytic leukemia in a HIV seropositive patient","volume":"26","author":"Calvo","year":"1997","journal-title":"Leuk. Lymphoma"},{"key":"ref_68","first-page":"1","article-title":"AIDS related malignant Disease at regional institute of medical sciences","volume":"44","author":"Gatphoh","year":"2001","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajh.20192","article-title":"Acute promyelocytic leukemia and HIV-1 infection: Case report and Review of the literature","volume":"77","author":"Kudva","year":"2004","journal-title":"Am. J. Haematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajh.20553","article-title":"Acute promyelocytic leukemia in an HIV-infected patient: A case report","volume":"81","author":"Laurenti","year":"2006","journal-title":"Am. J. Haematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2047-783X-14-1-42","article-title":"Acute promyelocytic leukemia after whole brain irradiation of primary brain lymphoma in an HIV-infected patient","volume":"14","author":"Boban","year":"2009","journal-title":"Eur. J. Med. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1182\/blood.V114.22.4166.4166","article-title":"The first case report of APL (acute promyelocytic leukemia) in an HIV positive patient on highly active antiretroviral therapy treated with arsenic trioxide","volume":"114","author":"Malik","year":"2009","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood.V84.8.2480.2480","article-title":"Effect of retinoic acid on HL-60 cells infected with human immunodeficiency virus type 1","volume":"84","author":"Semmel","year":"1994","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/10245330701255130","article-title":"All-trans retinoic acid attacks Reverse transcriptase resulting in inhibition of HIV-1 replication","volume":"12","author":"Maeda","year":"2007","journal-title":"Haematology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1097-2765(01)00255-6","article-title":"Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: Interference with early steps of viral replication","volume":"7","author":"Turelli","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1128\/JVI.77.5.3167-3180.2003","article-title":"As(2)O(3) enhances retroviral Reverse transcription and counteracts Ref1 antiviral activity","volume":"77","author":"Berthoux","year":"2003","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04312.x","article-title":"Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: The experiences of more than 25 years","volume":"163","author":"Hutter","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_78","first-page":"389","article-title":"Transplantation in HIV-infected subjects: Is cure possible?","volume":"2013","author":"Zaia","year":"2013","journal-title":"Haematol. Am. Soc. Haematol. Educ. Progr. Am."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2017-04-551606","article-title":"How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation","volume":"130","author":"Alvarnas","year":"2017","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/j.bbmt.2019.03.021","article-title":"Risks and Outcomes of allogeneic hematopoietic stem cell transplantation for hematologic malignancies in patients with HIV infection","volume":"25","author":"Arslan","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/ciy010","article-title":"Epidemiology and outcomes of hematopoietic stem cell transplantation in human immunodeficiency virus-positive patients from 1998 to 2012: A nationwide analysis","volume":"67","author":"Mehta","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbmt.2019.06.033","article-title":"Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: The BMT CTN-0903\/AMC-080 trial","volume":"25","author":"Ambinder","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V99.2.698","article-title":"Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome","volume":"99","author":"Kang","year":"2002","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0301-472X(01)00793-7","article-title":"Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV\/HCV coinfected patient with acute myeloid leukemia","volume":"30","author":"Antinori","year":"2002","journal-title":"Exp. Haematol."},{"key":"ref_85","first-page":"S344","article-title":"Allogenic stem cell transplantation in a patient with acute myeloid leukaemia and HIV, hepatitis C infections","volume":"33","author":"Shamansky","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/QAD.0b013e3280b01836","article-title":"Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART","volume":"21","author":"Mahlaoui","year":"2007","journal-title":"AIDS"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2008-05-157511","article-title":"Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation","volume":"112","author":"Woolfrey","year":"2008","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbmt.2008.12.348","article-title":"Feasibility of allogeneic peripheral blood stem cell transplantation (Allo-SCT) following reduced Intensity conditioning (RIC) in HIV+ patients with hematological malignancies","volume":"15","author":"Hamadani","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Nowak","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12185-009-0467-2","article-title":"Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART","volume":"91","author":"Oka","year":"2010","journal-title":"Int. J. Haematol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/bmt.2009.168","article-title":"Allo-SCT for hematological malignancies in the setting of HIV","volume":"45","author":"Polizzotto","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1097\/QAD.0000000000001240","article-title":"Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies","volume":"30","author":"Mulanovich","year":"2016","journal-title":"AIDS"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbmt.2015.08.006","article-title":"Safety and efficacy of combination antiretroviral therapy in human immunodeficiency virus-infected adults undergoing autologous or allogeneic hematopoietic cell transplantation for hematologic malignancies","volume":"22","author":"Johnston","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41409-018-0297-z","article-title":"Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced Intensity allogeneic stem cell transplant in HIV-infected patient with acute myeloid leukaemia","volume":"53","author":"Kanellopoulos","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0000000000002209","article-title":"Grupo Espa\u00f1ol de Trasplante Hematopoy\u00e9tico y Terapia Celular (GETH). Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological Disorders","volume":"33","author":"Kwon","year":"2019","journal-title":"AIDS"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"ref_97","first-page":"1343","article-title":"HIV remission after hematopoietic stem cell transplant","volume":"321","author":"Abbasi","year":"2019","journal-title":"JAMA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/1081\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:55:16Z","timestamp":1760172916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/1081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":98,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["ijms21031081"],"URL":"https:\/\/doi.org\/10.3390\/ijms21031081","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]}}}